Michela Parisi Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 2537 Chase St, Edgewater, CO 80214 Phone: 970-232-8909 |
Amanda Barker Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 2497 Eaton St, Edgewater, CO 80214 Phone: 405-471-1476 |
Alissa Lynae Arteaga Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 2255 Sheridan Blvd # C224, Edgewater, CO 80214 Phone: 720-575-9889 |
Alizea Farquharson, MA,LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 2024 Fenton St, Edgewater, CO 80214 Phone: 970-612-8791 |
Laura Wade Jaster, MA, NCC, ERYT Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 5700 W 25th Ave, Edgewater, CO 80214 Phone: 720-334-7124 |
Meghan Margaret Stetson Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 2255 Sheridan Blvd # C224, Edgewater, CO 80214 Phone: 720-575-9889 |
Sara M Kidd Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 2255 Sheridan Blvd # C224, Edgewater, CO 80214 Phone: 720-575-9889 |
News Archive
ImThera Medical, Inc., a privately held global medical device company, today announced that the U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) for its THN3 Clinical Study.
CyMedica Orthopedics, Inc. today announced that it has received a CE (Conformité Européenne) Mark for its QB1 Muscle Activation System. The product received its FDA 510(k) clearance in April 2015, and has since enjoyed a tremendous reception from orthopedic surgeons and knee patients across the United States.
In a national survey of practicing family physicians, pediatricians, internists and surgeons, the majority reported that their training in chronic care medicine was too thin overall to meet the demands of their practices.
A Cedars-Sinai research team led by Paul W. Noble, MD, chair of the Department of Medicine and director of the Women's Guild Lung Institute, has been awarded $628,816 by California's stem cell agency to develop a treatment for idiopathic pulmonary fibrosis, a deadly disease that destroys the lungs and damages other vital organs.
In a study published in the June 19 online edition of the journal Nature, a scientific team led by researchers from the University of California, San Diego School of Medicine visually monitored the dynamic cellular events that take place when cardiac regeneration occurs in zebrafish after cardiac ventricular injury. Their findings provide evidence that various cell lines in the heart are more plastic, or capable of transformation into new cell types, than previously thought.
› Verified 5 days ago